Key result
Nerolidol protects against doxorubicin-induced cardiotoxicity in rats by mitigating oxidative stress, inflammation, and apoptosis.
Why the study?
Clinical usage of doxorubicin is often limited by cardiotoxic effects, prompting evaluation of cardioprotective interventions to improve its use.
Does nerolidol attenuate oxidative stress, inflammation, and apoptosis in doxorubicin-induced acute cardiotoxicity in rats?
Does nerolidol attenuate oxidative stress, inflammation, and apoptosis in doxorubicin-induced acute cardiotoxicity in rats?
Nerolidol demonstrates cardioprotective effects against doxorubicin-induced acute cardiotoxicity in rats via antioxidant, anti-inflammatory, and antiapoptotic mechanisms.
Answers are grounded in this paper and cite their sources.
Should not change doxorubicin cardiotoxicity management; leaves open translation of nerolidol effects from rat models to humans.
The clinical usage of doxorubicin (DOX), a potent anthracycline antineoplastic drug, is often limited by its cardiotoxic effects. Thus, for improving usage of DOX, the aim of this study was to assess the cardioprotective effects of nerolidol (NERO) in a rat model of DOX-induced acute cardiotoxicity and examine underlying molecular mechanisms that contribute to these effects. To induce acute cardiotoxicity male albino Wistar rats were injected with single dose intraperitoneal DOX (12.5 mg/kg). The rats were treated with NERO (50 mg/kg, orally) for five days. DOX-injected rats showed elevated levels of cardiac marker enzymes and enhanced oxidative stress markers along with altered Nrf2/Keap1/HO-1 signaling pathways. DOX administration also induced the activation of NF-κB/MAPK signaling and increased the levels and expression of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) as well as expression of inflammatory mediators (iNOS and COX-2) in the heart. DOX also triggered DNA damage and apoptotic cell death in the myocardium. Additionally, histological studies revealed structural alterations of the myocardium. NERO treatment exhibited protection against the deleterious results of DOX on myocardium, as evidenced by the restoration of altered biochemical parameters, mitigated oxidative stress, inflammation, and apoptosis. The findings of the present study demonstrate that NERO provides cardioprotective effects against DOX-induced acute cardiotoxicity attributed to its potent antioxidant, anti-inflammatory, and antiapoptotic activities through modulating cellular signaling pathways.
No takes yet. Share an insight, caveat, or question.
Arunachalam et al. (2021) studied Doxorubicin-induced acute cardiotoxicity. Nerolidol vs. Doxorubicin alone (12.5 mg/kg) was evaluated on Cardioprotective effects (cardiac marker enzymes, oxidative stress, inflammation, and apoptosis). Nerolidol treatment protected against doxorubicin-induced acute cardiotoxicity in rats by restoring biochemical parameters and mitigating oxidative stress, inflammation, and apoptosis.
Synapse has enriched 10 related papers. Consider them for comparative context: